Fig. 1 · Structure
Documents & Downloads
Pranazepide
Cholecystokinin Receptor Antagonist
Pranazepide is a selective antagonist of the cholecystokinin-A receptor (CCK-A), implicated in regulating gastrointestinal functions and satiety. This compound exhibits significant biological activity by modulating neural signaling pathways associated with appetite control and gastrointestinal motility. Pranazepide is commonly utilized in pharmacological research focused on obesity, anxiolytic effects, and the role of CCK in the central nervous system.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 150408-73-4 |
| Applications | Cholecystokinin Receptor Antagonist |
| Formula | C26H19FN4O2 |
| Molecular Weight | 438.45 |
| Synonyms | FR120480 |
| SMILES | O=C1N2C3=C(CC2)C=CC=C3C(C4=C(C=CC=C4)F)=N[C@@H]1NC(C5=CC6=C(C=CC=C6)N5)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.